Clinical Trials in Minneapolis

Showing 6841-6860 of 14,456 trials

Losartan for Patients With COVID-19 Requiring Hospitalization

NCT04312009

This is a multi-center, double-blinded study of COVID-19 infected patients requiring inpatient hospital admission randomized 1:1 to daily Losartan or placebo for 7 days or hospital discharge.

Corona Virus InfectionAcute Respiratory Distress SyndromeSARS-CoV Infection

University of Minnesota205 participantsStarted Apr 2020

Gainesville, Florida, United States • Jacksonville, Florida, United States • Atlanta, Georgia, United States +10 more locations

TERMINATEDNA< 1 mile

SHIELD II Clinical Investigation

NCT02468778

The HeartMate PHP System is a temporary (\<6 hours) ventricular assist device indicated for use during high-risk percutaneous coronary interventions (PCI) performed electively or urgently in hemodynamically stable patients with severe coronary artery disease, when a heart team, including a cardiac surgeon, has determined high-risk PCI is the appropriate therapeutic option. Use of the HeartMate PHP Systems in these patients may prevent hemodynamic instability, which can result from repeat episodes of reversible myocardial ischemia that occur during planned temporary coronary occlusions and may reduce peri-and post-procedural adverse events.

Coronary Artery Disease

Abbott Medical Devices54 participantsStarted Aug 2015

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Los Angeles, California, United States +55 more locations

Losartan for Patients With COVID-19 Requiring Hospitalization

SHIELD II Clinical Investigation

Find Trials by Condition in Minneapolis

Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center

MOMENTUM 3 Continued Access Protocol

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

MOMENTUM 3 IDE Clinical Study Protocol

CentriMag RVAS U.S. Post-approval Study Protocol

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)

A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Participants With Chronic Kidney Disease (CKD), Stages 3 and 4

Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens

Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis

A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody

Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease

Dose-Ranging Study for Prolonged Postoperative Analgesia in Subject Undergoing Total Knee Arthroplasty

Investigating the Efficacy of a Mobile App Intervention to Change Youth and Their Families' Health Behaviours